Figure S2 showing characterization of iPSC colony 5. a Karyotype of iPSC colony 5 was normal. b qRT-PCR analysis showed expression of OCT4, SOX2, and NANOG of iPSC colony 5. PBMNCs of patient used as negative control, H1 embryonic stem cells used as positive control. c Immunofluorescence staining showed expression of TRA-1-60, SSEA4, OCT4, and NANOG. d Sections of teratomas stained with H&E (endoderm: pancreas; mesoderm: muscle; ectoderm: nerve fibers). All scale bars represent 100 Îźm. (DOCX 1261 kb
Characterization of iPSC lines. Figure S1. Immunostaining of DIAN iPSCs for pluripotency markers. iP...
showing expression of factors from episomal vectors. a pE3.1 plasmid construction process chart (upp...
Figure S2. Derivation of hESCs from diseased and frozen–thawed embryos using MTP. (A) ICM clump isol...
Figure S1. showing sequencing results of parental and inserted iPSCs. a Parental iPSCs have the know...
Table S3 presenting plasmids used for transfection of HEK293T cells and iPSCs. (DOCX 14 kb
Table S1. presenting antibodies used for immunofluorescence staining and flow cytometry analysis. (D...
Table S2. presenting primers used for characterization of hepatocytic functions. (DOCX 14 kb
Figure S3. showing off-target effects detection in successful inserted iPSCs. Using Cas-OFFinder, 17...
Figure S4. showing characterization of hepatocytic functions. Differentiated cells had functions of ...
Showing characterization of iPSCs derived from skin fibroblasts of a patient with hemoglobin E/beta-...
is Figure S1 showing cellular characteristics and HPC/HSC reprogramming. A Identification of HPC/HSC...
Showing gene expression profile of the differentiated cells. (a) qRT-PCR analysis of hematopoietic ...
Figure S1. H9-CD34+ cells were able to form hematopoietic colonies. Colony-forming assays were perfo...
is Figure S3 showing the cell morphology change and cell proliferation rate of HPC/HSCs compared wit...
Figure S3. Characterization of hESC lines derived from MTP. (A) Total transcripts OCT4, SOX2, and NA...
Characterization of iPSC lines. Figure S1. Immunostaining of DIAN iPSCs for pluripotency markers. iP...
showing expression of factors from episomal vectors. a pE3.1 plasmid construction process chart (upp...
Figure S2. Derivation of hESCs from diseased and frozen–thawed embryos using MTP. (A) ICM clump isol...
Figure S1. showing sequencing results of parental and inserted iPSCs. a Parental iPSCs have the know...
Table S3 presenting plasmids used for transfection of HEK293T cells and iPSCs. (DOCX 14 kb
Table S1. presenting antibodies used for immunofluorescence staining and flow cytometry analysis. (D...
Table S2. presenting primers used for characterization of hepatocytic functions. (DOCX 14 kb
Figure S3. showing off-target effects detection in successful inserted iPSCs. Using Cas-OFFinder, 17...
Figure S4. showing characterization of hepatocytic functions. Differentiated cells had functions of ...
Showing characterization of iPSCs derived from skin fibroblasts of a patient with hemoglobin E/beta-...
is Figure S1 showing cellular characteristics and HPC/HSC reprogramming. A Identification of HPC/HSC...
Showing gene expression profile of the differentiated cells. (a) qRT-PCR analysis of hematopoietic ...
Figure S1. H9-CD34+ cells were able to form hematopoietic colonies. Colony-forming assays were perfo...
is Figure S3 showing the cell morphology change and cell proliferation rate of HPC/HSCs compared wit...
Figure S3. Characterization of hESC lines derived from MTP. (A) Total transcripts OCT4, SOX2, and NA...
Characterization of iPSC lines. Figure S1. Immunostaining of DIAN iPSCs for pluripotency markers. iP...
showing expression of factors from episomal vectors. a pE3.1 plasmid construction process chart (upp...
Figure S2. Derivation of hESCs from diseased and frozen–thawed embryos using MTP. (A) ICM clump isol...